MobiHealthNews

Abbott lands EUA for $5 rapid COVID-19 test

Abbott has scored yet another Emergency Use Authorization for rapid coronavirus testing – this one, named BinaxNOW COVID-19 Ag Card, come in the form of a card and can provide results in 15 minutes.
MedTech Dive

Abbott’s cancer diagnostics vision: ‘There’s always a hunger to make these tests better’

Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, ...
Nasdaq

Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside

The test, run on Abbott's portable i-STAT® Alinity® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), or concussion The test produces ...
Nasdaq

Health Canada Approves Abbott's Whole Blood Rapid Test To Assess Concussions

(RTTNews) - Abbott Laboratories (ABT) Monday said that its i-STAT TBI test cartridge for use with whole blood has been approved by the Health Canada. The test, run on Abbott's portable i-STAT Alinity ...
FierceBiotech

Abbott advances its hand-held, rapid blood test for TBI, concussions with new FDA clearance

Abbott has obtained a new clearance from the FDA for its rapid blood test to check out patients suspected of having a concussion or a mild traumatic brain injury. With a 15-minute result given by a ...
Reuters

Abbott says to buy diagnostic test maker Alere for $5.8 bln

Feb 1 (Reuters) - Abbott Laboratories said it would buy Alere Inc for $5.8 billion and become the leader in point-of-care diagnostic testing, a market that is growing as physicians increasingly adopt ...